The National Institutes of Health Awards Sanford Research to Support Clinical Trial
By IHR Magazine, . Updated
Nearly $11.7 million has been awarded over the course of five years to The Cancer Biology Research Centre at Sanford Research from the National Institutes of Health to support clinical trial research for head, neck and paediatric cancers.
“Our hope is that this latest NIH grant allows us to improve cancer care for this region,” said Keith Miskimins, Ph.D., who is the project’s principal investigator and director of the Cancer Biology Research Centre at Sanford Research. “A grant this large positions the participating scientists well for long-term sustainability in the research world.”
“Basic research is important because it leads to discoveries that might someday be translated to patients,” said David Pearce, Ph.D., executive vice president of Sanford Research.
Sections: Industry News
More in Industry News
- Jungbunzlauer’s New Director Lands in the Middle of a Citric Acid Duty Fight
- NHP labelling Bulletin 13 turns two relabels into one reprint
- CHFA Launch Pad 2026 : deux finalistes québécois, et ni l’un ni l’autre n’a besoin d’une licence de Santé Canada
- CHFA Launch Pad 2026: Canada’s Innovation Pipeline Has Left the Supplement Aisle
- Retailers Want Inventory AI. Almost None Have It.
- The Ingredient Aisle Is Reorganising Around Proof — and That’s Where Niche Retailers Win